Pre-operative anaemia: Prevalence, consequences and approaches to management

Blood Transfusion

Volumn 13, Issue 3, 2015, Pages 370-379

  Muñoz, Manuel ^a   Gómez Ramírez, Susana ^b   Campos, Arturo ^c   Ruiz, Joaquín ^c   Liumbruno, Giancarlo M ^d  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b Xanit International Hospital   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Iron therapy; Preoperative anaemia; Recombinant human erythropoietin; Transfusion

Indexed keywords

IRON;

ANEMIA; BLOOD TRANSFUSION; ERYTHROCYTE; HUMAN; IRON DEFICIENCY; IRON THERAPY; LENGTH OF STAY; META ANALYSIS (TOPIC); MORBIDITY; MORTALITY; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PREVALENCE; REVIEW; SYSTEMATIC REVIEW (TOPIC); TREATMENT OUTCOME; BLOOD; PATHOPHYSIOLOGY; PREOPERATIVE CARE; PROCEDURES;

ANEMIA; HUMANS; PREOPERATIVE CARE; PREVALENCE;

EID: 84946821893     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2015.0014-15     Document Type: Review

References (87)

1. Kassebaum NJ, Jasrasaria R, Naghavi M, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood 2014; 123: 615-24.
2. Guralnik JM, Eisenstaedt RS, Ferrucci L, et al. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 2004; 104: 2263-8.
3. Gaskell H, Derry S, Andrew Moore R, McQuay HJ. Prevalence of anaemia in older persons: systematic review. BMC Geriatr 2008; 8: 1.
4. Koch CG, Li L, Sun Z, et al. From bad to worse: anemia on admission and hospital-acquired anemia. J Patient Saf 2014; DOI 10.1097/PTS.0000000000000142.
5. Muñoz M, Gómez-Ramírez S, Cobos A, Enguix A. Prevalence and severity of anaemia among medical patients from different hospital departments. Transfus Alternat Transfus Med 2011; 12: 30.
6. Ludwig H, Van Belle S, Barrett-Lee P, et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer 2004; 40: 2293-306.
7. Wu WC, Schifftner TL, Henderson WG, et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 2007; 297: 2481-8.
8. Beattie WS, Karkouti K, Wijeysundera DN, Tait G. Risk associated with preoperative anemia in noncardiac surgery: a single-center cohort study. Anesthesiology 2009; 110: 574-81.
9. Musallam KM, Tamim HM, Richards T, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 2011; 378: 1396-407.
10. Rosencher N, Kerkkamp HE, Macheras G, et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003; 43: 459-69.
11. Gombotz H, Rehak PH, Shander A, Hofmann A. Blood use in elective surgery: the Austrian benchmark study. Transfusion 2007; 47: 1468-80.
12. Gombotz H, Rehak PH, Shander A, Hofmann A. The second Austrian benchmark study for blood use in elective surgery: results and practice change. Transfusion 2014; 54: 2646-57.
13. Saleh E, McClelland DB, Hay A, et al. Prevalence of anaemia before major joint arthroplasty and the potential impact of preoperative investigation and correction on perioperative blood transfusions. Br J Anaesth 2007; 99: 801-8.
14. Bisbe E, Castillo J, Sáez M, et al. Prevalence of preoperative anemia and hematinic deficiencies in patients scheduled for elective major orthopedic surgery. Transfus Alternat Transfus Med 2008; 10: 166-73.
15. Jans Ø, Jorgensen C, Kehlet H, Johansson PI. Role of preoperative anemia for risk of transfusion and postoperative morbidity in fast-track hip and knee arthroplasty. Transfusion 2014; 54: 717-26.
16. Leichtle SW, Mouawad NJ, Lampman R, et al. Does preoperative anemia adversely affect colon and rectal surgery outcomes? J Am Coll Surg 2011; 212: 187-94.
17. Gupta PK, Sundaram A, Mactaggart JN, et al. Preoperative anemia is an independent predictor of postoperative mortality and adverse cardiac events in elderly patients undergoing elective vascular operations. Ann Surg 2013; 258: 1096-102.
18. David O, Sinha R, Robinson K, Cardone D. The prevalence of anaemia, hypochromia and microcytosis in preoperative cardiac surgical patients. Anaesth Intensive Care 2013; 41: 316-21.
19. Elmistekawy E, Rubens F, Hudson C, et al. Preoperative anaemia is a risk factor for mortality and morbidity following aortic valve surgery. Eur J Cardiothorac Surg 2013; 44: 1051-5.
20. Karkouti K, Wijeysundera DN, Beattie WS. Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study. Circulation 2008; 117: 478-84.
21. Kim C, Connell H, McGeorge A, Hu R. Prevalence of preoperative anaemia in patients having first-time cardiac surgery and its impact on clinical outcome. A retrospective observational study. Perfusion 2015; 30: 277-83.
22. Kulier A, Levin J, Moser R, et al. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation 2007; 116: 471-9.
23. Scrascia G, Guida P, Caparrotti SM, et al. Incremental value of anemia in cardiac surgical risk prediction with the European System for Cardiac Operative Risk Evaluation (EuroSCORE) II model. Ann Thorac Surg 2014; 98: 869-75.
24. Muñoz M, Ariza D, Gómez-Ramírez S, et al. Preoperative anemia in elective cardiac surgery: prevalence, risk factors, and influence on postoperative outcome. Transfus Alternat Transfus Med 2010; 11: 47-56.
25. Ferrucci L, Guralnik JM, Bandinelli S, et al. Unexplained anaemia in older persons is characterised by low erythropoietin and low levels of pro-inflammatory markers. Br J Haematol 2007; 136: 849-55.
26. Muñoz M, García-Erce JA, Remacha AF. Disorders of iron metabolism. Part 1: Molecular basis of iron homeostasis. J Clin Pathol 2011: 64: 281-6.
27. Muñoz M, García-Erce JA, Remacha AF. Disorders of iron metabolism. Part II: Iron deficiency and iron overload . J Clin Pathol 2011; 64: 287-96.
28. Muñoz M, García-Erce JA, Leal-Noval SR. Is there still a role for recombinant erythropoietin in the management of anemia of critical illness?. Med Clin (Barc) 2009; 132: 749-55. [In Spanish].
29. Díaz Espallardo C, Laso Morales MJ, Colilles Calvet C, et al. The multidisciplinary approach is useful for optimising preoperative haemoglobin in colorectal cancer surgery. Cir Esp 2011; 89: 392-9. [In Spanish].
30. Lunn JN, Elwood OC. Anaemia and surgery. BMJ 1970; 3: 71-3.
31. Ranucci M, Di Dedda U, Castelvecchio S, et al. Surgical and Clinical Outcome Research (SCORE) Group. Impact of preoperative anemia on outcome in adult cardiac surgery: a propensity-matched analysis. Ann Thorac Surg 2012; 94: 1134-41.
32. Leal-Noval SR, Muñoz-Gómez M, Jiménez-Sánchez M, et al. Red blood cell transfusion in non-bleeding critically ill patients with moderate anemia: is there a benefit? Intensive Care Med 2013; 39:45-53.
33. Ferraris VA, Davenport DL, Saha SP, et al. Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Arch Surg 2012; 147: 49-55.
34. Acheson AG, Brookes MJ, Spahn DR. Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery-systematic review and meta-analysis. Ann Surg 2012; 256: 235-44.
35. Saleh A, Small T, Chandran Pillai AL, et al. Allogenic blood transfusion following total hip arthroplasty: results from the nationwide inpatient sample, 2000 to 2009. J Bone Joint Surg Am 2014; 96: e155.
36. Ranucci M, Baryshnikova E, Castelvecchio S, Pelissero G; Surgical and Clinical Outcome Research (SCORE) Group. Major bleeding, transfusions, and anemia: the deadly triad of cardiac surgery. Ann Thorac Surg 2013; 96: 478-85.
37. Muñoz M, Ariza D, Campos A, et al. The cost of post-operative shed blood salvage after total knee arthroplasty: an analysis of 1,093 consecutive procedures. Blood Transfus 2013; 11: 260-71.
38. Shander A, Hofmann A, Ozawa S, et al. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010; 50: 753-65.
39. Toner RW, Pizzi L, Leas B, et al. Costs to hospitals of acquiring and processing blood in the US: a survey of hospital-based blood banks and transfusion services. Appl Health Econ Health Policy 2011; 9: 29-37.
40. Abraham I, Sun D. The cost of blood transfusion in Western Europe as estimated from six studies. Transfusion 2012; 52: 1983-8.
41. Norgaard A, De Lichtenberg TH, Nielsen J, Johansson PI. Monitoring compliance with transfusion guidelines in hospital departments by electronic data capture. Blood Transfus 2014; 12: 509-19.
42. Roubinian NH, Escobar GJ, Liu V, et al. Trends in red blood cell transfusion and 30-day mortality among hospitalized patients. Transfusion 2014; 54: 2678-86.
43. Carson JL, Grossman BJ, Kleinman S, et al. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med 2012; 157: 49-58.
44. Leal-Noval SR, Muñoz M, Asuero M, et al. Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document". Blood Transfus 2013; 11: 585-610.
45. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013; 30: 270-382.
46. Leal-Noval SR, Arellano-Orden V, Maestre-Romero A, et al. Impact of national transfusion indicators on appropriate blood usage in critically ill patients. Transfusion 2011; 51: 1957-65.
47. Goodnough LT. Trends in blood utilization. Transfus Med 2014; 24: 2.
48. Rohde JM, Dimcheff DE, Blumberg N, et al. Health careassociated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA 2014; 311: 1317-26.
49. Shander A, Van Aken H, Colomina MJ, et al. Patient blood management in Europe. Br J Anaesth 2012; 109: 55-68.
50. World Health Assembly. WHA 63.12 (resolution). Availability, safety and quality of blood products, 2010. Available at: http:// apps.who.int/gb/ebwha/pdf-files/WHA63/A63-R12-en.pdf. Accessed on 27/08/2013.
51. Beris P, Muñoz M, García-Erce JA, et al. Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth 2008; 100: 599-604.
52. Goodnough LT, Maniatis A, Earnshaw P, et al. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth 2011; 106: 13-22.
53. Society for the Advancement of Blood Management (SABM). Anemia in the pre-surgical patient. Recognition, diagnosis, and management. Available at: http://www.sabm.org/publications. Accessed on 12/02/2015.
54. Muñoz M, Gómez-Ramirez S, Campos A. Iron supplementation for perioperative anaemia in patient blood management. EMJ Hema 2014; 1: 123-132.
55. Hallet J, Hanif A, Callum J, et al. The impact of perioperative iron on the use of red blood cell transfusions in gastrointestinal surgery: a systematic review and meta-analysis. Transfus Med Rev 2014; 28: 205-11.
56. Rogers BA, Cowie A, Alcock C, Rosson JW. Identification and treatment of anaemia in patients awaiting hip replacement. Ann R Coll Surg Engl 2008; 90: 504-7.
57. Lidder PG, Sanders G, Whitehead E, et al. Pre-operative oral iron supplementation reduces blood transfusion in colorectal surgery - a prospective, randomised, controlled trial. Ann R Coll Surg Engl 2007; 89: 418-21.
58. Okuyama M, Ikeda K, Shibata T, et al. Preoperative iron supplementation and intraoperative transfusion during colorectal cancer surgery. Surg Today 2005; 35: 36-40.
59. Quinn M, Drummond RJ, Ross F, et al. Short course preoperative ferrous sulphate supplementation - is it worthwhile in patients with colorectal cancer? Ann R Coll Surg Engl 2010; 92: 569-72.
60. Lachance K, Savoie M, Bernard M, et al. Oral ferrous sulfate does not increase preoperative hemoglobin in patients scheduled for hip or knee arthroplasty. Ann Pharmacother 2011; 45: 764-70.
61. Nagaraju SP, Cohn A, Akbari A, et al. Heme iron polypeptide for the treatment of iron deficiency anemia in non-dialysis chronic kidney disease patients: a randomized controlled trial. BMC Nephrol 2013; 14: 64.
62. Pisani A, Riccio E, Sabbatini M, et al. Effect of oral liposomal iron versus intravenous iron for the treatment of iron deficiency anaemia in CKD patients: a randomized trial. Nephrol Dial Transplant 2015; 30: 645-52.
63. Theusinger OM, Leyvraz PF, Schanz U, et al. Treatment of iron deficiency anemia in orthopedic surgery with intravenous iron: efficacy and limits: a prospective study. Anesthesiology 2007; 107: 923-7.
64. Díez-Lobo AI, Fisac-Martín MP, Bermejo-Aycar I, Muñoz M. Preoperative intravenous iron administration corrects anemia and reduces transfusion requirement in women undergoing abdominal hysterectomy. Transfus Alternatives Transfus Med 2007; 9: 114-9.
65. Gonzalez-Porras JR, Colado E, Conde MP, et al. An individualized pre-operative blood saving protocol can increase pre-operative haemoglobin levels and reduce the need for transfusion in elective total hip or knee arthroplasty. Transfus Med 2009; 19: 35-42.
66. Bisbe E, García-Erce JA, Díez-Lobo AI, Muñoz M; Anaemia Working Group España. A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery. Br J Anaesth 2011; 107: 477-8.
67. Muñoz M, Campos A, García-Erce JA. Intravenous iron in colo-rectal cancer surgery. Semin Hematol 2006; 34 (Suppl 6): S36-8.
68. Basora M, Colomina MJ, Tio M, et al. Optimizing preoperative haemoglobin with intravenous iron. Br J Anaesth 2013; 110: 488-90.
69. Weber EW, Slappendel R, Hémon Y, et al. Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST). Eur J Anaesthesiol 2005; 22: 249-57.
70. So-Osman C, Nelissen RG, Koopman-van Gemert AW, et al. Patient blood management in elective total hip-and kneereplacement surgery (Part 1): a randomized controlled trial on erythropoietin and blood salvage as transfusion alternatives using a restrictive transfusion policy in erythropoietin-eligible patients. Anesthesiology 2014; 120: 839-51.
71. Karkouti K, McCluskey SA, Evans L, et al. Erythropoietin is an effective clinical modality for reducing RBC transfusion in joint surgery. Can J Anesth 2005; 52: 363-8.
72. Rosencher N, Poisson D, Albi A, et al. Two injections of erythropoietin correct moderate anemia in most patients awaiting orthopedic surgery. Can J Anesth 2005; 52: 160-5.
73. Alghamdi AA, Albanna MJ, Guru V, Brister SJ. Does the use of erythropoietin reduce the risk of exposure to allogeneic blood transfusion in cardiac surgery? A systematic review and meta-analysis. J Card Surg 2006; 21: 320-6.
74. Cladellas M, Farré N, Comín-Colet J, et al. Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement. Am J Cardiol 2012; 110: 1021-6.
75. Muñoz M, Gómez-Ramírez S, Martín-Montañez E, Auerbach M. Perioperative anemia management in colorectal cancer patients: a pragmatic approach. World J Gastroenterol 2014; 20: 1972-85.
76. Devon KM, McLeod RS. Pre and peri-operative erythropoietin for reducing allogeneic blood transfusions in colorectal cancer surgery. Cochrane Database Syst Rev 2009; CD007148.
77. Bennett CL, Spiegel DM, Macdougall IC, et al. A review of safety, efficacy, and utilization of erythropoietin, darbepoetin, and peginesatide for patients with cancer or chronic kidney disease: a report from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost 2012; 38: 783-96.
78. Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris VA, Ferraris SP, Saha SP, et al; Society of Cardiovascular Anesthesiologists Special Task Force on Blood Transfusion, Spiess BD, Shore-Lesserson L, Stafford-Smith M, et al. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 2007; 83 (Suppl 5): S27-86.
79. Cuenca J, Garcia-Erce JA, Martinez F, et al. Preoperative haematinics and transfusion protocol reduce the need for transfusion after total knee replacement. Int J Surg 2007; 5: 89-94.
80. Theusinger OM, Kind SL, Seifert B, et al. Patient Blood Management in Orthopaedic surgery - a four year follow up from 2008 to 2011 at the Balgrist University Hospital in Zurich, Switzerland on transfusion requirements and blood loss. Blood Transfus 2014; 12: 195-203.
81. Muñoz M, Gómez-Ramírez S, Cuenca J, et al. Very-shortterm perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion 2014; 54: 289-99.
82. Serrano-Trenas JA, Ugalde PF, Cabello LM, et al. Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial. Transfusion 2011; 51: 97-104.
83. Kateros K, Sakellariou VI, Sofianos IP, Papagelopoulos PJ. Epoetin alfa reduces blood transfusion requirements in patients with intertrochanteric fracture. J Crit Care 2010; 25: 348-53.
84. Ootaki Y, Yamaguchi M, Yoshimura N, et al. The efficacy of preoperative administration of a single dose of recombinant human erythropoietin in pediatric cardiac surgery. Heart Surg Forum 2007; 10: E115-9.
85. Weltert L, D'Alessandro S, Nardella S, et al. Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study. J Thorac Cardiovasc Surg 2010; 139: 621-6.
86. Yoo YC, Shim KK, Kim JC, et al. Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. Anesthesiology 2011; 115: 929-37.
87. Weltert L, Rondinelli B, Bello R, et al. A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial. Transfusion 2015; DOI: 10.1111/trf.13027.